Cowen and Company’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,139,280
Closed -$48.7M 649
2023
Q3
$48.7M Buy
6,139,280
+3,573,000
+139% +$22.5M 3.41% 4
2023
Q2
$14.2M Buy
2,566,280
+998,000
+64% +$5.47M 1.18% 21
2023
Q1
$8.92M Buy
1,568,280
+244,936
+19% +$1.62M 1.05% 25
2022
Q4
$9.25M Buy
1,323,344
+212,900
+19% +$2.19M 0.97% 22
2022
Q3
$4.08M Buy
1,110,444
+1,100,444
+11,004% +$12.7M 0.39% 40
2022
Q2
$104K Sell
10,000
-16,824
-63% -$250K 0.01% 240
2022
Q1
$560K Sell
26,824
-115,297
-81% -$2.52M 0.05% 146
2021
Q4
$3.64M Buy
+142,121
New +$3.93M 0.33% 59
2021
Q3
Sell
-33,467
Closed -$1.16M 665
2021
Q2
$1.34M Buy
+33,467
New +$1.36M 0.07% 106

Other funds holding MSOS

Cowen and Company's MSOS Position: Q4 2023 in Review

Cowen and Company sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2023, closing a stake of 6,139,280 shares — an estimated $48.7M sold.

Cowen and Company first reported a position in MSOS in Q2 2021 and held it in 9 quarters. The position peaked at $48.7M in Q3 2023. 171 funds tracked by Wall St. Rank hold MSOS as of Q4 2023.

  • Cowen and Company reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2023 after selling out during the quarter.
  • Cowen and Company sold 6,139,280 AdvisorShares Pure US Cannabis ETF shares in Q4 2023, an estimated $48.7M.
  • Cowen and Company first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and held it in 9 quarters.
  • Cowen and Company's AdvisorShares Pure US Cannabis ETF position peaked at $48.7M in Q3 2023.
  • 171 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.